Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy

Philip A. Hines*, Rosa Gonzalez-Quevedo, Apolline I. O. M. Lambert, Rosanne Janssens, Barbara Freischem, Jordi Torren Edo, Ivo J. T. M. Claassen, Anthony J. Humphreys

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number508
Number of pages21
JournalFrontiers in medicine
Volume7
DOIs
Publication statusPublished - 23 Sep 2020

Keywords

  • regulatory science
  • regulation
  • innovation
  • stakeholder engagement
  • patient access
  • benefit-risk assessment

Cite this